Skip to main content
Premium Trial:

Request an Annual Quote

Veeda's India, UK Research Labs to Use Thermo Fisher's LIMS

NEW YORK (GenomeWeb News) - Thermo Fisher Scientific said today that Veeda Clinical Research will use its lab information management system in Veeda’s facilities in Ahmedabad, India, and in Oxford, UK.
 
Veeda’s Ahmedabad branch is already using Thermo Fisher’s Watson LIMS, while the UK lab is currently in the validation process and should be using the software “in the near future,” Thermo said.
 
The Anglo-Indian company Veeda, which provides clinical pathology, biomarker, and bioanalytical services, also has offices in Belgium, Germany, France, and the US.
 
The Ahmedabad lab offers services for small molecule pharmacokinetics, and the UK facility offers biomarker, large molecule pharmacokinetics, immunogenicity assay development, validation, and sample analysis.
 
Financial terms of the agreement were not released.
 

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.